Presentations
Biomarck Pharmaceuticals presentation at H.C. Wainwright 2021 Global Life Sciences Conference on March 9-10, 2021
Peptide Inhibitors of MARCKS Reverse Endotoxin Induced Uveitis in Rats presented at ARVO on May 6, 2021
A Phase II, Placebo-Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients with Acute Respiratory Distress Syndrome
